Case study: Innovative model identifies high-risk people for priority COVID-19 vaccination

Case study: Innovative model identifies high-risk people for priority COVID-19 vaccination Funded by the NIHR, the research team, comprising experts from 12 institutions, collaborated to develop a new approach to identifying patients’ risk at a population level. 

Using its findings, the team developed a clinical risk prediction model, QCovid®. It then tested how well this model predicted hospital admissions or deaths from COVID-19 infection using the pre-existing health records of a separate set of people. National Institute for Health Research